gemcitabine 200 MG in 5.26 ML Injection

RxCUI
1720977
RxNorm name
gemcitabine 200 MG in 5.26 ML Injection
Display name
gemcitabine 200 MG in 5.26 ML Injection
Full name
gemcitabine 200 MG in 5.26 ML Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:24

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 7 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
GemcitabineGEMCITABINEHospira, Inc.dc02a23b-3ff9-4441-aa91-8e9e629a73152026-04-27Warnings, Adverse reactionsExact identifier
rxcui: 1720977
GemcitabineGEMCITABINEHospira, Inc.e18ed1cb-7dd0-4001-bfda-17d1f4587fb82026-04-27Warnings, Adverse reactionsExact identifier
rxcui: 1720977
GemcitabineGEMCITABINEHikma Pharmaceuticals USA Inc.d80176fe-3e8b-48be-87c2-9c603013b3fa2025-10-24Warnings, Adverse reactionsExact identifier
rxcui: 1720977
GemcitabineGEMCITABINE HYDROCHLORIDEMeitheal Pharmaceuticals Inc.c0b1b715-9ff8-43ca-9e49-465f1f3800842025-07-23Warnings, Adverse reactionsExact identifier
rxcui: 1720977
GemcitabineGEMCITABINESagent Pharmaceuticals22af3507-4b4f-4cad-9d61-89ffc4aabbc72025-02-03Warnings, Adverse reactionsExact identifier
rxcui: 1720977
GemcitabineGEMCITABINE HYDROCHLORIDEMylan Institutional LLC06dd9d40-74fc-4409-93b1-a46be71263312024-11-11Warnings, Adverse reactionsExact identifier
rxcui: 1720977
GemcitabineGEMCITABINE HYDROCHLORIDEMeitheal Pharmaceuticals Inc.73ae04d8-38f9-4d3d-b0c2-71d22af1fc862024-08-05Warnings, Adverse reactionsExact identifier
rxcui: 1720977

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 7 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
dc02a23b-3ff9-4441-aa91-8e9e629a7315gemcitabine 200 MG in 5.26 ML Injection [PSN] · 5.26 ML gemcitabine 38 MG/ML Injection [SCD] · gemcitabine (as gemcitamine HCl) 200 MG per 5.26 ML Injection [SY] · gemcitabine 200 MG per 5.26 ML Injection [SY]428These highlights do not include all the information needed to use GEMCITABINE INJECTION safely and effectively. See full prescribing information for GEMCITABINE INJECTION. GEMCITABINE injection, for intravenous use Initial U.S. Approval: 199620260427
22af3507-4b4f-4cad-9d61-89ffc4aabbc7gemcitabine 200 MG in 5.26 ML Injection [PSN] · 5.26 ML gemcitabine 38 MG/ML Injection [SCD] · gemcitabine (as gemcitamine HCl) 200 MG per 5.26 ML Injection [SY] · gemcitabine 200 MG per 5.26 ML Injection [SY]48These highlights do not include all the information needed to use GEMCITABINE INJECTION safely and effectively. See full prescribing information for GEMCITABINE INJECTION. GEMCITABINE injection, for intravenous use Initial U.S. Approval: 199620250203
73ae04d8-38f9-4d3d-b0c2-71d22af1fc86gemcitabine 200 MG in 5.26 ML Injection [PSN] · 5.26 ML gemcitabine 38 MG/ML Injection [SCD] · gemcitabine (as gemcitamine HCl) 200 MG per 5.26 ML Injection [SY] · gemcitabine 200 MG per 5.26 ML Injection [SY]47These highlights do not include all the information needed to use GEMCITABINE INJECTION safely and effectively. See full prescribing information for GEMCITABINE INJECTION. GEMCITABINE injection, for intravenous use Initial U.S. Approval: 199620240805
06dd9d40-74fc-4409-93b1-a46be7126331gemcitabine 200 MG in 5.26 ML Injection [PSN] · 5.26 ML gemcitabine 38 MG/ML Injection [SCD] · gemcitabine (as gemcitamine HCl) 200 MG per 5.26 ML Injection [SY] · gemcitabine 200 MG per 5.26 ML Injection [SY]46These highlights do not include all the information needed to use GEMCITABINE INJECTION safely and effectively. See full prescribing information for GEMCITABINE INJECTION. GEMCITABINE injection, for intravenous use Initial U.S. Approval: 199620241111
d80176fe-3e8b-48be-87c2-9c603013b3fagemcitabine 200 MG in 5.26 ML Injection [PSN] · 5.26 ML gemcitabine 38 MG/ML Injection [SCD] · gemcitabine (as gemcitamine HCl) 200 MG per 5.26 ML Injection [SY] · gemcitabine 200 MG per 5.26 ML Injection [SY]44HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use GEMCITABINE INJECTION safely and effectively. See full prescribing information for GEMCITABINE INJECTION. GEMCITABINE injection, for intravenous use Initial U.S. Approval: 199620251024
c0b1b715-9ff8-43ca-9e49-465f1f380084gemcitabine 200 MG in 5.26 ML Injection [PSN] · 5.26 ML gemcitabine 38 MG/ML Injection [SCD] · gemcitabine (as gemcitamine HCl) 200 MG per 5.26 ML Injection [SY] · gemcitabine 200 MG per 5.26 ML Injection [SY]41These highlights do not include all the information needed to use GEMCITABINE INJECTION safely and effectively. See full prescribing information for GEMCITABINE INJECTION. GEMCITABINE injection, for intravenous use Initial U.S. Approval: 199620250723
57b80f66-208d-4903-9443-e4c9239e3207gemcitabine 200 MG in 5.26 ML Injection [PSN] · 5.26 ML gemcitabine 38 MG/ML Injection [SCD] · gemcitabine (as gemcitamine HCl) 200 MG per 5.26 ML Injection [SY] · gemcitabine 200 MG per 5.26 ML Injection [SY]41These highlights do not include all the information needed to use GEMCITABINE INJECTION safely and effectively. See full prescribing information for GEMCITABINE INJECTION. GEMCITABINE injection, for intravenous use. Initial U.S. Approval: 199620200110